Chris Hansis, MD, PhD
Founder & CEO
Dr. Chris Hansis is the Founder & CEO of Phase Clinical Services, a full-service CRO in Mt. Kisco, New York concentrating on Phase 0-II oncology clinical trials. Previously he was the Founder & CEO of the preclinical research services provider TransCell Science until its acquisition by BioIVT, for which he served as the Chief Scientific Officer. He was also Research Faculty, Principal Investigator, and Director at the University of Southern California and New York University Medical Schools, focusing on the generation of human embryonic stem and iPS cells and molecular lineage determination in preimplantation embryos.
David J. Gibboni, PhD, MBA
Dr. David Gibboni is heading Business Development at Phase Clinical Services. Previously he was the Senior Director and Vice President of Business Development at Invicro (a Konica Minolta company providing global imaging services). Prior, he served as Senior Director of Business Development at WorldCare Clinical (a global imaging CRO). He also served as Director of Business Development for 5 years at ICON (a top 100 CRO) and Business Development Manager at Air Liquide Healthcare. David holds a PhD degree in organometallic chemistry from Yale University and an MBA from Saint Joseph’s University.
Xiaomei Wang, MD, PhD
Dr. Xiaomei Wang is heading Scientific Affairs at Phase Clinical Services. She completed postdoctoral studies at The Children’s Hospital of Philadelphia, Department of Hematology. Amongst other prizes, she was awarded First Prize for Excellence in Research at the Fels Institute for Cancer Research and Molecular Biology at Temple University School of Medicine, where she also completed her PhD in Molecular and Cellular Biology. Xiaomei obtained an MD degree from Peking University Health Science Center and worked as a Research Assistant at Peking Union Medical College Hospital, both of which are top institutions in China.
Shuang Zhou, PhD
Business & Research Development
Dr. Shuang Zhoucompleted postdoctoral studies at Harvard Medical School, Beth Israel Deaconess Medical Center, and Baylor Scott & White Health in oncology, neuroscience and immunology after obtaining her PhD degree in pharmaceutical sciences from North Dakota State University. She subsequently held research positions at the University of Houston and in commercial oncology biotech. Dr. Zhou has published extensively, is a patent holder, won a number of awards and honors, served as guest editor and reviewer for multiple peer-reviewed journals, and held positions in professional societies.
Donald Hickey, MDes (RCA) BABAI
A designer, engineer and software developer by training (Royal College of Art, Trinity College Dublin, National College of Ireland), Donald Hickey had multiple advanced positions in the clinical trials, educational and technology industries, many in combination with his entrepreneurial activities. He is based in Dublin, Ireland and serves as Phase Clinical’s European Liaison with his in-depth knowledge of the markets and wide contacts in this area.